1,1100
25-ноября-24 13:20:23
15 мин. задержка
Акции
+0,0300
+2,78%
Сегодняшний диапазон
1,0600 - 1,1200
ISIN
N/A
Источник
NASDAQ
Clearside Biomedical Announces First Patients Enrolled in Phase 1/2a Clinical Trial of CLS-AX (axitinib injectable suspension) for the Treatment of Wet AMD
12 янв 2021 07:05:00 Источник Nasdaq GlobeNewswire
Clearside Biomedical Announces Pricing of $12 Million Registered Direct Offering
06 янв 2021 07:05:00 Источник Nasdaq GlobeNewswire